Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Luxeptinib | 1616428-23-9 | 99.0% | C25H17F4N5O2 | 10MG
Supplier: Medchemexpress LLC HY13953510MG
Luxeptinib is an orally active, reversible, non-covalent small-molecule inhibitor that targets FLT3 and BTK signaling pathways. Provided for research use, it inhibits downstream phosphorylation events (including STAT5, AKT, and ERK1/2), induces cell-cycle arrest and apoptosis in leukemic cells, and includes manufacturer guidance for preparation and storage.
- Orally active reversible pan-FLT3 and pan-BTK inhibitor.
- Inhibits phosphorylation of FLT3 and STAT5 in cellular assays.
- Induces cell-cycle arrest, apoptosis, and autophagy in leukemia models.
- Supplied as a powder with recommended storage conditions for stability.
- Manufacturer provides suggested in-vitro stock concentrations and assay guidance.
- Suitable for in-vitro cell proliferation assays at 0.1-10 μM.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?